Bioscience Neutraceuticals, Inc. announced earnings results for the second quarter ended June 30, 2019. For the second quarter, the company announced operating loss was USD 10,090 compared to USD 18,519 a year ago. Net loss was USD 15,314 compared to USD 26,618 a year ago. For the half year, operating loss was USD 451,009 compared to USD 20,007 a year ago. Net loss was USD 462,411 compared to USD 38,750 a year ago. Basic loss per share from continuing operations was USD 0.1 compared to USD 0.16 a year ago.